GlassScriptPhysician profile
Ari B Gutman
NPI 1376715706
$33,613.17
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $18K · 2021: $175 · 2022: $30.00.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $25,807.40 | 2019-2020 | |
| Dusa Pharmaceuticals, INC. | $6,691.44 | 2019 | |
| Abbvie INC. | $290.66 | 2019-2020 | |
| Eli Lilly and Company | $175.00 | 2021 | |
| Sanofi-Aventis U.S. LLC | $99.99 | 2019 | |
| Novartis Pharmaceuticals Corporation | $70.53 | 2019-2020 | |
| Lilly USA, LLC | $70.22 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $67.17 | 2019 | |
| Celgene Corporation | $65.29 | 2019 | |
| Genzyme Corporation | $41.19 | 2019-2020 | |
| Epi Health, LLC | $30.00 | 2022 | |
| Janssen Biotech, INC. | $29.17 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $27.29 | 2019 | |
| Galderma Laboratories, L.P. | $27.16 | 2019 | |
| Aclaris Therapeutics, INC. | $21.80 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofrontera INC. | $19.90 | 2019 | |
| Amgen INC. | $19.03 | 2020 | |
| Ucb, INC. | $17.35 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $15.08 | 2019 | |
| Pfizer INC. | $14.58 | 2019 | |
| Journey Medical Corporation | $12.92 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ari Gutman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.